Gyre

Business

Gyre Therapeutics president Ma Songjiang sells $22,336 in stock By Investing.com

SAN DIEGO—Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), recently sold a portion of his holdings in the company. According…

Read More »
Back to top button